Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | LIPE | Q05469 | 15/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluazifop SCHEMBL29370478 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL1010239 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL1559717 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop-P SCHEMBL29370487 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL67403 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop-P SCHEMBL118853 | 0.97 | LMNA (0.62) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop-P SCHEMBL11006621 | 0.96 | LMNA (0.60) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL9362442 | 0.96 | LMNA (0.60) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL10513170 | 0.96 | LMNA (0.60) | LMNARAB9ALIPEMAPTNPSR1 | |
| Fluazifop SCHEMBL16827270 | 0.94 | LMNA (0.58) | LMNARAB9ALIPEMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2285215-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | Fasgen, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |
| WO-2009149066-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN, INC. (US) | 2009-12-10 | — | — | WO | disclosed |
| EP-2086943-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | Fasgen, LLC (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008057585-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN LLC (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1539730-A4 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN INC (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2007014249-A2 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | JOHNS HOPKINS UNIVERSITY (US) | 2007-02-01 | — | — | WO | disclosed |
| WO-2007014247-A2 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | JOHNS HOPKINS UNIVERSITY (US) | 2007-02-01 | — | — | WO | disclosed |
| EP-1539730-A1 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | Fasgen Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004005277-A1 | NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME | FASGEN, INC. (US) | 2004-01-15 | — | — | WO | disclosed |